Literature DB >> 17310851

Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma.

Q C Yang1, B F Zeng, Z M Shi, Y Dong, Z M Jiang, J Huang, Y M Lv, C X Yang, Y W Liu.   

Abstract

The purpose of this study is to determine whether trichostatin A (TSA), a HDAC specific inhibitor, inhibited the induction and functional activity of hypoxia-inducible factor-1 a(HIF-1a) and hypoxia-induced angiogenesis in vitro in human osteosarcoma. The relationship between expression of HIF-1a proteion and angiogenesis in tumor specimens was also studied. Hypoxic regulation of VEGF was studied by RT-PCR, western blotting analysis and enzyme linked immunosorbent assay. The expression of HIF-la and VEGF in human osteosarcoma specimens was studied by immunohistochemical analysis. Under hypoxia, no regulation of HIF-1a mRNA expression was found. However, HIF-1a protein levels increased dramatically in response to hypoxia. Hypoxia increased VEGF mRNA level, but it was significantly inhibited by trichostatin A in a time- and dose-dependent manner (p < 0.05). Strongly positive immunostaining for HIF-1a and VEGF were detectable in the nuclear and cytoplasm of osteosarcoma cells. HIF-1a expressing cells were prominent in areas with high MVD. Significant correlation were found between HIF-1a expression and MVD (p = 0.005, r = 0.767), as well as between VEGF and MVD (p < 0.002, r = 0.701) by Spearman's rank coefficient analysis. These results indicated that HIF-1a is a key factor responsible for angiogenesis by the induction of VEGF. TSA downregulates hypoxia-response genes and hypoxia-induced angiogenesis by the suppression of HIF-1a activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17310851

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  17 in total

1.  Age-related macular degeneration (AMD) mitochondria modulate epigenetic mechanisms in retinal pigment epithelial cells.

Authors:  Sonali Nashine; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Exp Eye Res       Date:  2019-06-19       Impact factor: 3.467

Review 2.  Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.

Authors:  Sabnam Parbin; Swayamsiddha Kar; Arunima Shilpi; Dipta Sengupta; Moonmoon Deb; Sandip Kumar Rath; Samir Kumar Patra
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

3.  Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.

Authors:  Jie Zhang; Yao-tiao Deng; Jie Liu; Yu-qing Wang; Ting-wu Yi; Bo-yan Huang; Sha-sha He; Bo Zheng; Yu Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-10       Impact factor: 4.553

4.  Silencing of hypoxia-inducible factor-1α promotes thyroid cancer cell apoptosis and inhibits invasion by downregulating WWP2, WWP9, VEGF and VEGFR2.

Authors:  Zhong-Yang Ding; Yun-Juan Huang; Jian-Dong Tang; Gan Li; Pan-Qiang Jiang; Hao-Tian Wu
Journal:  Exp Ther Med       Date:  2016-10-20       Impact factor: 2.447

5.  Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells.

Authors:  Melinda Bence; Julia Koller; Maria Sasvari-Szekely; Gergely Keszler
Journal:  J Neural Transm (Vienna)       Date:  2011-07-23       Impact factor: 3.575

Review 6.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

7.  Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.

Authors:  Xiao-Bing Cui; Xia Guo; Shi-You Chen
Journal:  Cardiovasc Res       Date:  2013-05-21       Impact factor: 10.787

8.  The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines.

Authors:  Min-Gyun Kim; Jhang Ho Pak; Won Ho Choi; Jeong-Yeol Park; Joo-Hyun Nam; Jong-Hyeok Kim
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

9.  Bone sarcomas: from biology to targeted therapies.

Authors:  Nathalie Gaspar; Angela Di Giannatale; Birgit Geoerger; Françoise Redini; Nadège Corradini; Natacha Enz-Werle; Franck Tirode; Perrine Marec-Berard; Jean-Claude Gentet; Valérie Laurence; Sophie Piperno-Neumann; Odile Oberlin; Laurence Brugieres
Journal:  Sarcoma       Date:  2012-11-27

Review 10.  Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?

Authors:  Aleksander M Grabiec; Paul P Tak; Kris A Reedquist
Journal:  Arthritis Res Ther       Date:  2008-10-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.